Cargando…
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
BACKGROUND: Thiopurines (azathioprine and mercaptopurine) are frequently used immunosuppressive drugs to maintain remission in patients with inflammatory bowel disease. Half of the conventional thiopurine-derivative users have to discontinue treatment within 5 years, mainly because of intolerable ad...
Autores principales: | Meijer, Berrie, Seinen, Margien L., van Egmond, Remco, Bouma, Gerd, Mulder, Chris J. J., van Bodegraven, Adriaan A., de Boer, Nanne K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647119/ https://www.ncbi.nlm.nih.gov/pubmed/28617756 http://dx.doi.org/10.1097/MIB.0000000000001168 |
Ejemplares similares
-
Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018) -
How I treat my inflammatory bowel disease-patients with thiopurines?
por: Meijer, Berrie, et al.
Publicado: (2016) -
Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study
por: Meijer, Berrie, et al.
Publicado: (2017) -
Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016) -
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)